• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Influence of interferon on the functional and structural changes of central nervous system from the viewpoints of aging and gender

Research Project

Project/Area Number 21590857
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionIwate Medical University

Principal Investigator

SUZUKI Kazuyuki  岩手医科大学, 医学部, 教授 (00137499)

Co-Investigator(Kenkyū-buntansha) SAWARA Kei  岩手医科大学, 医学部, 助教 (40405816)
TAKIKAWA Yasuhiro  岩手医科大学, 医学部, 教授 (50254751)
MIYASAKA Akio  岩手医科大学, 医学部, 助教 (80382597)
WANG Tei  岩手医科大学, 医学部, 助教 (70416171)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsウイルス / インターフェロン / 薬剤反応 / 細胞・組織 / シグナル伝達 / 肝炎ウイルス / 薬物反応 / 細胞・祖時期
Research Abstract

Clinical study : Among the patients with chronic hepatitis C treated with PEG-IFN/Ribavirin, the neuropsychiatric symptoms(insomnia, poor mood and depressive state) appeared more commonly in males than females. The age and sex were not associated with the sustained viral response. The self-rating depression scale(SDS) points worsened during the treatment and PDG-PET scan revealed a tendency of decreased cerebral glucose metabolism(CMRglu) in the entire brain regions, However, SDS points and CMRglu returned to pre-treatment values after the therapy. However, no relationship was seen between two parameters. Experimental study : The expressions of both IFN receptors(IFN-R1 and R2) were detectable in the cultured human astrocytes. A physiologically-relevant concentrations of IFNα2a and α2b(i. e., 2 IU/ml) both inhibited the expression of the INF receptors and significantly decreased the proliferation of human astrocytes. In contrast, IFN-β did not affect astrocyte proliferation. IFN-α treatment inhibited the Glut-1 expression, resulting in deceased glucose consumption. These effects were associated, in part, with the alterations in cytokines such as interleukin-8.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (20 results)

All 2012 2011 2010 2009

All Journal Article (16 results) (of which Peer Reviewed: 11 results) Presentation (4 results)

  • [Journal Article] Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/Ribavirin2012

    • Author(s)
      Miyasaka A, Kumagai I, Abe K and Suzuki K
    • Journal Title

      Hepato-Gastroenterology

      Volume: 59 Pages: 794-799

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Negative regulation of human astrocytes by IFNα: the involvement of growth inhibition and impaired glucose utilization2012

    • Author(s)
      Wang T, Takikawa Y, Sawara K, Yoshida S, Suzuki K
    • Journal Title

      Neurochem Res

      Volume: (in press)

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/Ribavirin2012

    • Author(s)
      Miyasaka A, Suzuki K, et al.(4名中4番目)
    • Journal Title

      Hepato-Gastroenterology

      Volume: 59(In press) Issue: 115-116

    • DOI

      10.5754/hge11570

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon a-2b for advanced hepatocellular carcinoma with portal venous invasion2011

    • Author(s)
      Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K
    • Journal Title

      Cancer

      Volume: 118 Issue: 13 Pages: 3302-3310

    • DOI

      10.1002/cncr.26648

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serotype 1高ウイルス量C型慢性肝炎に対するペグインターフェロンα-2b、リバビリン併用療法の有用性:東北地区における多施設共同研究成績2011

    • Author(s)
      宮坂昭生、坂本十一、福田真作、後藤隆、大西洋英、上野義之、下瀬川徹、斉藤貴史、河田純男、大平弘正、小松真史、阿部弘一、鈴木一幸
    • Journal Title

      肝臓

      Volume: 28 Pages: 652-661

    • NAID

      10029822412

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients2010

    • Author(s)
      Ohsawa M, Kato K, Itai K, Tanno K, Fujishima Y, Konda R, Okayama A, Abe K, Suzuki K, Nakamura M, Onoda T, Kawamura K, Sakata K, Akiba T, Fujioka T
    • Journal Title

      J Epidemiol

      Volume: 20 Pages: 30-39

    • NAID

      10026251297

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] C型肝炎ウイルスの検診-わが国の実態と課題2010

    • Author(s)
      宮坂昭生、鈴木一幸
    • Journal Title

      総合臨床

      Volume: 59 Pages: 623-624

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
  • [Journal Article] 肝性脳症の治療のup-date2010

    • Author(s)
      鈴木一幸
    • Journal Title

      日本消化器病学会雑誌

      Volume: 107 Pages: 14-21

    • Related Report
      2011 Final Research Report
  • [Journal Article] 肝性脳症の治療のup-data(総説)2010

    • Author(s)
      鈴木一幸
    • Journal Title

      日本消化器病学会雑誌

      Volume: 107 Pages: 14-21

    • Related Report
      2010 Annual Research Report
  • [Journal Article] Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure2009

    • Author(s)
      Sawara K, Desjardins P, Chatauret N, Kato A, Suzuki K, Butterworth RF
    • Journal Title

      Neurochem Int

      Volume: 55 Pages: 119-123

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma with portal venous invasion : preliminary results2009

    • Author(s)
      Kasai K, Kuroda H, Ushio A, Sawara K, Takikawa Y, Suzuki K
    • Journal Title

      Hepatol Res

      Volume: 39 Pages: 117-125

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] A randomized trial of 24 weeks versus 48 weeks of peginterferonα-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1 : a multicenter national study in Japan2009

    • Author(s)
      Iwasaki Y, Shiratori H, Hige S, Nishiguchi S, Takagi H, Onji M, Yoshida H, Izumi N, Kohgo Y, Yamamoto K, Sato N, Shibuya A, Saito H, Sata M, Suzuki K, Kaneko S, Moriyama M, Omata M
    • Journal Title

      Hepatol Int

      Volume: 3 Pages: 468-479

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] 私の処方潜在性肝性脳症の治療2009

    • Author(s)
      鈴木一幸
    • Journal Title

      Modern Physician

      Volume: 29 Pages: 109-109

    • Related Report
      2011 Final Research Report
  • [Journal Article] Alterations in expression of genes coding for proteins of the neuro-vascular unit in ischemic liver failure.2009

    • Author(s)
      Sawara K, Desjardings P, Chatauret N, Kato A, Suzuki K, Butterworth RF.
    • Journal Title

      Neurochem Int 55

      Pages: 119-123

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma with portal venous invasion : preliminary results2009

    • Author(s)
      Kasai K, Kuroda H, Ushio A, Sawara K, Takikawa Y, Suzuki K
    • Journal Title

      Hepatol Res 39

      Pages: 117-125

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 私の処方 潜在性肝性脳症の治療2009

    • Author(s)
      鈴木一幸
    • Journal Title

      Modern Physician 29

      Pages: 109-109

    • Related Report
      2009 Annual Research Report
  • [Presentation] Interferon-α inhibits the proliferation of human astrocyte and decrease the expression glucose transporter Glut-12011

    • Author(s)
      Wang T, Takikawa Y, Yoshida S, Sawara K, Suzuki K
    • Organizer
      22^<st> APDW
    • Place of Presentation
      Singapore, Malaysia
    • Year and Date
      2011-10-07
    • Related Report
      2011 Final Research Report
  • [Presentation] Interferon-α inhibits the proliferation of human astrocyte and decrease the expression of glucose transporter Glut-12011

    • Author(s)
      Takikawa Y, Suzuki K, et al.(5名中5番目)
    • Organizer
      Asia Pacific Digestive Weeks (APDW)
    • Place of Presentation
      Singapore
    • Year and Date
      2011-10-02
    • Related Report
      2011 Annual Research Report
  • [Presentation] Cerebral glucose metabolism and neuropsychiatric symptoms in chronic hepatitis C patients under antiviral therapy2011

    • Author(s)
      Sawara K, Yoshida S, Oikawa A, Miyasaka A, Endo R, Takikawa Y, Kato A, Suzuki K
    • Organizer
      21^<st> APASL
    • Place of Presentation
      Bangkok, Thailand
    • Year and Date
      2011-02-17
    • Related Report
      2011 Final Research Report
  • [Presentation] Cerebral glucose metabolism and neuropsychiatric symptoms in chronic hepatitis C patients under antiviral therapy2011

    • Author(s)
      K Sawara, K Suzuki., et al., (8人中8番目)
    • Organizer
      The Conference of the Asia Pacific Association for the Study of the Liver
    • Place of Presentation
      バンコック(タイ)
    • Related Report
      2010 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi